Thermo Fisher Scientific

Yahoo Finance • 9 days ago

All J.P. Morgan's top stock picks for 2026

[Countdown to 2026. Loading year from 2025 to 2026. New year start concept.] SmileStudioAP J.P. Morgan identifies specific traits that define their Best Ideas for 2026. These companies typically possess: * Strong Financial Health: Rob... Full story

Yahoo Finance • 10 days ago

Here’s What Lifted Thermo Fisher Scientific (TMO) in Q3

Bristol Gate Capital Partners, an investment management company, published its Q3 2025 investor letter for the “US Equity Strategy”. A copy of the letter can be downloaded here. The strategy underperformed the benchmark, the S&P 500® Total... Full story

Yahoo Finance • 10 days ago

BofA Raises Thermo Fisher (TMO) Target as Biopharma Recovery Comes Into View

Thermo Fisher Scientific Inc. (NYSE:TMO) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026.BofA Raises Thermo Fisher (TMO) Target as Biopharma Recovery Comes Into View On December 15, Bank of America raised its price tar... Full story

Yahoo Finance • 12 days ago

What Makes Thermo Fisher (TMO) a Good Investment Choice?

Artisan Partners, an investment management company, released its “Artisan Value Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The equity market rally persisted in the third quarter as investors igno... Full story

Yahoo Finance • 12 days ago

Validea Detailed Fundamental Analysis - TMO

Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth... Full story

Yahoo Finance • 18 days ago

Favorable Results and Improved Guidance Lifted Thermo Fisher Scientific (TMO) in Q3

Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 Index surged in the third quarter, driven by in... Full story

Yahoo Finance • 21 days ago

Analysts See 12% Upside To Thermo Fisher Scientific Inc. (TMO)

Thermo Fisher Scientific Inc. (NYSE:TMO) is among the 14 Best S&P 500 Stocks to Buy Now. As of the close of business on December 17, Wall Street analysts have a consensus Strong Buy rating on the stock, with a one-year average share price... Full story

Yahoo Finance • 26 days ago

Thermo Fisher Scientific Expands Gibco™ Bacto™ Portfolio with Next-Generation, Chemically Defined Media to Boost E. coli Biomanufacturing Productivity

New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production with confidence WALTHAM, Mass., December 15, 2025--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving... Full story

Yahoo Finance • 29 days ago

Becton Dickinson, Bio-Rad, and Thermo Fisher Propel Safety and Automation in Blood Collection Tubes—New Market Report Highlights $7Billion Opportunity

Company Logo The blood collection tubes market presents opportunities through innovation in automated systems, advanced materials, and digital traceability to enhance workflow efficiency and compliance. Demand is driven by personalized me... Full story

Yahoo Finance • 29 days ago

Oppenheimer Analyst Maintains An Outperform Rating On Broadcom Inc. (AVGO)

Broadcom Inc. (NASDAQ:AVGO) is among the 13 Best Nanotechnology Stocks to Buy Now.Thermo Fisher Scientific’s (TMO) Dividend: Steady Payouts in a Growing Market TheFly reported on December 5, 2025, that Oppenheimer analyst Rick Schafer had... Full story

Yahoo Finance • 29 days ago

Morgan Stanley Analyst Is Bullish On Thermo Fisher Scientific Inc. (TMO)

Thermo Fisher Scientific Inc. (NYSE:TMO) is among the 13 Best Nanotechnology Stocks to Buy Now. Morgan Stanley Analyst Is Bullish On Thermo Fisher Scientific Inc. (TMO) According to The Fly, on December 2, 2025, Morgan Stanley analyst Kal... Full story

Yahoo Finance • 29 days ago

Autoimmune Disease Diagnosis Market to Surge to USD 8.98 Billion by 2031

Company Logo The autoimmune disease diagnosis market is poised to grow from USD 5.57 billion in 2025 to USD 8.98 billion by 2031, exhibiting a CAGR of 8.3%. Key growth drivers include rising autoimmune disorder prevalence, increased aware... Full story

Yahoo Finance • 30 days ago

Guru Fundamental Report for TMO

Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-f... Full story

Yahoo Finance • 30 days ago

PayPal downgraded, Roku upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Jefferies upgraded Roku (ROKU) to Buy... Full story

Yahoo Finance • last month

Synopsys upgraded, Warner Bros. downgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly. Claim 50% Off TipRanks Premium and Invest with Confidence... Full story

Yahoo Finance • last month

Synopsys upgraded, Warner Bros. downgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Rosenblatt upgraded Synopsys (SNPS) to... Full story

Yahoo Finance • last month

DNA Diagnostics Market Projected to Surge by 66% to USD 21.69 Billion by 2030

Company Logo The DNA Diagnostics Market is set to surge from USD 13.07 billion in 2024 to USD 21.69 billion by 2030, growing at a CAGR of 8.81%. Key trends driving this growth include the emergence of liquid biopsies, the rise of direct-t... Full story

Yahoo Finance • last month

In Vitro Diagnostic Quality Control Market: Strategy & Trends with Forecasts by Assay Type, by Place, by Product, by Manufacturer and by Country - Situation Analysis with Executive & Consultant Guides

Dublin, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The "In Vitro Diagnostic Quality Control Market: Strategy & Trends with Forecasts by Assay Type, by Place, by Product, by Manufacturer and by Country - Situation Analysis with Executive & Consult... Full story

Yahoo Finance • last month

Should Newtyn’s Stake And T‑Mobile Lease Shift Array Digital Infrastructure’s (AD) Investment Narrative?

Newtyn Management recently disclosed a new US$67.5 million position in Array Digital Infrastructure, acquiring 1.35 million shares and making the stock the fund’s fourth-largest holding as the company completes its shift from a wireless op... Full story

Yahoo Finance • last month

What Made Thermo Fisher Scientific (TMO) a Solid Performer in Q3?

Harding Loevner, an asset management company, released its “Global Equity Strategy” third-quarter 2025 investor letter.  A copy of the letter can be downloaded here. The fund returned 2.62% gross (2.52% net) in the third quarter of 2025, c... Full story